Are Nayzilam and Fycompa the Same Thing?
Nayzilam is used for acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient's usual seizure pattern.
Fycompa is used treat drug-resistant partial-onset seizures.
Both Nayzilam and Fycompa may interact with other drugs that can make you sleepy (other benzodiazepines and sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, opioids, alcohol).
Withdrawal symptoms may occur if you suddenly stop taking Nayzilam. If a patient withdraws from Fycompa, there may be an increase in the frequency of seizures.
What Are Possible Side Effects of Nayzilam?
Common side effects of Nayzilam include:
- nasal discomfort,
- throat irritation, and
- runny nose
What Are Possible Side Effects of Fycompa?
Common side effects of Fycompa include:
- weight gain,
- joint pain,
- back pain, and
- problems maintaining balance.
- changes in mood, behavior, or personality,
- unusual thoughts,
- paranoid behavior,
- panic attacks,
- thoughts about hurting someone else, and
- suicidal or homicidal ideation and threats.
Tell your doctor if you have serious side effects of Fycompa including trouble sleeping, talking more than usual, trouble walking, loss of balance or coordination, an accidental fall, severe dizziness, spinning sensation (vertigo), or feeling like you might pass out.
What Is Nayzilam?
Nayzilam (midazolam) is a benzodiazepine indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient's usual seizure pattern in patients with epilepsy 12 years of age and older.
What Is Fycompa?
Fycompa (perampanel) is a non-competitive AMPA receptor antagonist, which belongs to a new class of drugs to treat drug-resistant partial-onset seizures in patients with epilepsy ages 12 years and older.
What Drugs Interact With Nayzilam?
Nayzilam may interact with other drugs that can make you sleepy (other benzodiazepines and sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, opioids, alcohol), ketoconazole, itraconazole, and clarithromycin. Tell your doctor all medications and supplements you use.
What Drugs Interact With Fycompa?
Fycompa may interact with other drugs that make you sleepy or slow your breathing (sleeping pills, narcotic pain medicines, muscle relaxers, or medicines for anxiety, depression, or seizures), bosentan, nafcillin, pentobarbital, St. John's wort, rifabutin, rifapentine, rifampin, and HIV medications. Tell your doctor all medications and supplements you use.
How Should Nayzilam Be Taken?
The initial dose of Nayzilam is one spray (5 mg dose) administered into one nostril. A second dose of one additional spray (5 mg dose) Nayzilam may be administered into the opposite nostril after 10 minutes if the patient has not responded to the initial dose.
How Should Fycompa Be Taken?
Starting dose of Fycompa is 2 mg taken once daily at bedtime. Patients taking anti-eleptic drugs (AEDs) should start on 4 mg of Fycompa. Dosage may be increased based on how well patients tolerate Fycompa. The maximum recommended dose is 12 mg taken once daily. Fycompa is not recommended for patients with decreased liver or kidney function, or patients on dialysis.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
FDA. Nayzilam Drug Information.
Eisai. FycompaDrug Information.